{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:26:04Z","timestamp":1790414764626,"version":"4.1.0"},"reference-count":236,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"abstract":"<jats:p>Background. Kawasaki disease is an acute self-limited vasculitis of childhood that is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in \u223c15% to 25% of untreated children and may lead to ischemic heart disease or sudden death.<\/jats:p>\n                  <jats:p>Methods and Results. A multidisciplinary committee of experts was convened to revise the American Heart Association recommendations for diagnosis, treatment, and long-term management of Kawasaki disease. The writing group proposes a new algorithm to aid clinicians in deciding which children with fever for \u22655 days and \u22644 classic criteria should undergo electrocardiography, receive intravenous gamma globulin (IVIG) treatment, or both for Kawasaki disease. The writing group reviews the available data regarding the initial treatment for children with acute Kawasaki disease, as well for those who have persistent or recrudescent fever despite initial therapy with IVIG, including IVIG retreatment and treatment with corticosteroids, tumor necrosis factor-\u03b1 antagonists, and abciximab. Long-term management of patients with Kawasaki disease is tailored to the degree of coronary involvement; recommendations regarding antiplatelet and anticoagulant therapy, physical activity, follow-up assessment, and the appropriate diagnostic procedures to evaluate cardiac disease are classified according to risk strata.<\/jats:p>\n                  <jats:p>Conclusions. Recommendations for the initial evaluation, treatment in the acute phase, and long-term management of patients with Kawasaki disease are intended to assist physicians in understanding the range of acceptable approaches for caring for patients with Kawasaki disease. The ultimate decisions for case management must be made by physicians in light of the particular conditions presented by individual patients.<\/jats:p>","DOI":"10.1542\/peds.2004-2182","type":"journal-article","created":{"date-parts":[[2004,12,11]],"date-time":"2004-12-11T17:27:41Z","timestamp":1102786061000},"page":"1708-1733","source":"Crossref","is-referenced-by-count":1052,"title":["Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association"],"prefix":"10.1542","volume":"114","author":[{"given":"Jane W.","family":"Newburger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Gewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd Y.","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford T.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann F.","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ferrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Baltimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter R.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Levison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Pallasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Falace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn A.","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,12,1]]},"reference":[{"key":"2021120819410821900_R1","unstructured":"Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi.\u20081967;16 :178"},{"key":"2021120819410821900_R2","doi-asserted-by":"crossref","unstructured":"Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation.\u20081996;94 :1379\u2013 1385","DOI":"10.1161\/01.CIR.94.6.1379"},{"key":"2021120819410821900_R3","doi-asserted-by":"crossref","unstructured":"Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation.\u20081993;87 :1776\u2013 1780","DOI":"10.1161\/01.CIR.87.5.1776"},{"key":"2021120819410821900_R4","doi-asserted-by":"crossref","unstructured":"Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr.\u20081991;119 :279\u2013 282","DOI":"10.1016\/S0022-3476(05)80742-5"},{"key":"2021120819410821900_R5","doi-asserted-by":"crossref","unstructured":"Landing BH, Larson EJ. Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics.\u20081977;59 :651\u2013 662","DOI":"10.1542\/peds.59.5.651"},{"key":"2021120819410821900_R6","unstructured":"Gee SJ. Cases of morbid anatomy: aneurysms of coronary arteries in a boy. St Bartholomew's Hosp Rep. 1871;7"},{"key":"2021120819410821900_R7","doi-asserted-by":"crossref","unstructured":"Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med.\u20081995;149 :779\u2013 783","DOI":"10.1001\/archpedi.1995.02170200069011"},{"key":"2021120819410821900_R8","doi-asserted-by":"crossref","unstructured":"Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: a brief history. Pediatrics.\u20082000;106(2) . Available at: www.pediatrics.org\/cgi\/content\/full\/106\/2\/e27","DOI":"10.1542\/peds.106.2.e27"},{"key":"2021120819410821900_R9","doi-asserted-by":"crossref","unstructured":"Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics.\u20082001;107(3) . Available at: www.pediatrics.org\/cgi\/content\/full\/107\/3\/e33","DOI":"10.1542\/peds.107.3.e33"},{"key":"2021120819410821900_R10","doi-asserted-by":"crossref","unstructured":"Holman RC, Curns AT, Belay ED, Steiner CA, Schonberger LB. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics.\u20082003;112 :495\u2013 501","DOI":"10.1542\/peds.112.3.495"},{"key":"2021120819410821900_R11","doi-asserted-by":"crossref","unstructured":"Chang RK. The incidence of Kawasaki disease in the United States did not increase between 1988 and 1997. Pediatrics.\u20082003;111 :1124\u2013 1125","DOI":"10.1542\/peds.111.5.1124"},{"key":"2021120819410821900_R12","doi-asserted-by":"crossref","unstructured":"Davis RL, Waller PL, Mueller BA, Dykewicz CA, Schonberger LB. Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med.\u20081995;149 :66\u2013 69","DOI":"10.1001\/archpedi.1995.02170130068016"},{"key":"2021120819410821900_R13","doi-asserted-by":"crossref","unstructured":"Bronstein DE, Dille AN, Austin JP, Williams CM, Palinkas LA, Burns JC. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J.\u20082000;19 :1087\u2013 1091","DOI":"10.1097\/00006454-200011000-00012"},{"key":"2021120819410821900_R14","doi-asserted-by":"crossref","unstructured":"Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr.\u20082000;137 :250\u2013 252","DOI":"10.1067\/mpd.2000.105150"},{"key":"2021120819410821900_R15","doi-asserted-by":"crossref","unstructured":"Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988\u20131997. Pediatrics.\u20082002;109(6) . Available at: www.pediatrics.org\/cgi\/content\/full\/109\/6\/e87","DOI":"10.1542\/peds.109.6.e87"},{"key":"2021120819410821900_R16","doi-asserted-by":"crossref","unstructured":"Momenah T, Sanatani S, Potts J, Sandor GG, Human DG, Patterson MW. Kawasaki disease in the older child. Pediatrics.\u20081998;102(1) . Available at: www.pediatrics.org\/cgi\/content\/full\/102\/1\/e7","DOI":"10.1542\/peds.102.1.e7"},{"key":"2021120819410821900_R17","doi-asserted-by":"crossref","unstructured":"Yanagawa H, Nakamura Y, Yashiro M, Ojima T, Tanihara S, Oki I, Zhang T. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics.\u20081998;102(6) . Available at: www.pediatrics.org\/cgi\/content\/full\/102\/6\/e65","DOI":"10.1542\/peds.102.6.e65"},{"key":"2021120819410821900_R18","doi-asserted-by":"crossref","unstructured":"Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr.\u20082001;90 :40\u2013 44","DOI":"10.1111\/j.1651-2227.2001.tb00253.x"},{"key":"2021120819410821900_R19","doi-asserted-by":"crossref","unstructured":"Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics.\u20081989;84 :666\u2013 669","DOI":"10.1542\/peds.84.4.666"},{"key":"2021120819410821900_R20","unstructured":"Harada F, Sada M, Kamiya T, Yanase Y, Kawasaki T, Sasazuki T. Genetic analysis of Kawasaki syndrome. Am J Hum Genet.\u20081986;39 :537\u2013 539"},{"key":"2021120819410821900_R21","doi-asserted-by":"crossref","unstructured":"Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics.\u20081995;95 :475\u2013 479","DOI":"10.1542\/peds.95.4.475"},{"key":"2021120819410821900_R22","doi-asserted-by":"crossref","unstructured":"Quasney MW, Bronstein DE, Cantor RM, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease. Pediatr Res.\u20082001;49 :686\u2013 690","DOI":"10.1203\/00006450-200105000-00013"},{"key":"2021120819410821900_R23","doi-asserted-by":"crossref","unstructured":"Newburger JW, Taubert KA, Shulman ST, et al. Summary and abstracts of the Seventh International Kawasaki Disease Symposium: December 4\u20137, 2001, Hakone, Japan. Pediatr Res.\u20082003;53 :153\u2013 157","DOI":"10.1203\/00006450-200301000-00026"},{"key":"2021120819410821900_R24","doi-asserted-by":"crossref","unstructured":"Kaneko K, Obinata K, Katsumata K, Tawa T, Hosaka A, Yamashiro Y. Kawasaki disease in a father and daughter. Acta Paediatr.\u20081999;88 :791\u2013 792","DOI":"10.1111\/j.1651-2227.1999.tb00048.x"},{"key":"2021120819410821900_R25","doi-asserted-by":"crossref","unstructured":"Bruckheimer E, Bulbul Z, McCarthy P, Madri JA, Friedman AH, Hellenbrand WE. Images in cardiovascular medicine: Kawasaki disease: coronary aneurysms in mother and son. Circulation.\u20081998;97 :410\u2013 411","DOI":"10.1161\/01.CIR.97.4.410"},{"key":"2021120819410821900_R26","doi-asserted-by":"crossref","unstructured":"Uehara R, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease in parents and children. Acta Paediatr.\u20082003;92 :694\u2013 697","DOI":"10.1111\/j.1651-2227.2003.tb00602.x"},{"key":"2021120819410821900_R27","doi-asserted-by":"crossref","unstructured":"Bell DM, Brink EW, Nitzkin JL, et al. Kawasaki syndrome: description of two outbreaks in the United States. N Engl J Med.\u20081981;304 :1568\u2013 1575","DOI":"10.1056\/NEJM198106253042603"},{"key":"2021120819410821900_R28","doi-asserted-by":"crossref","unstructured":"Rauch AM. Kawasaki syndrome: review of new epidemiologic and laboratory developments. Pediatr Infect Dis J.\u20081987;6 :1016\u2013 1021","DOI":"10.1097\/00006454-198711000-00002"},{"key":"2021120819410821900_R29","doi-asserted-by":"crossref","unstructured":"Rauch AM, Glode MP, Wiggins JW Jr, et al. Outbreak of Kawasaki syndrome in Denver, Colorado: association with rug and carpet cleaning. Pediatrics.\u20081991;87 :663\u2013 669","DOI":"10.1542\/peds.87.5.663"},{"key":"2021120819410821900_R30","doi-asserted-by":"crossref","unstructured":"Treadwell TA, Maddox RA, Holman RC, et al. Investigation of Kawasaki syndrome risk factors in Colorado. Pediatr Infect Dis J.\u20082002;21 :976\u2013 978","DOI":"10.1097\/00006454-200210000-00018"},{"key":"2021120819410821900_R31","doi-asserted-by":"crossref","unstructured":"Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DY. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J.\u20081988;7 :863\u2013 866","DOI":"10.1097\/00006454-198807120-00006"},{"key":"2021120819410821900_R32","doi-asserted-by":"crossref","unstructured":"Rauch AM, Kaplan SL, Nihill MR, Pappas PG, Hurwitz ES, Schonberger LB. Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina. A high endemic rate and a new environmental risk factor. Am J Dis Child.\u20081988;142 :441\u2013 444","DOI":"10.1001\/archpedi.1988.02150040095027"},{"key":"2021120819410821900_R33","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: the fifth look. Arch Pediatr Adolesc Med.\u20082002;156 :162\u2013 165","DOI":"10.1001\/archpedi.156.2.162"},{"key":"2021120819410821900_R34","doi-asserted-by":"crossref","unstructured":"Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics.\u20081978;61 :100\u2013 107","DOI":"10.1542\/peds.61.1.100"},{"key":"2021120819410821900_R35","doi-asserted-by":"crossref","unstructured":"Burns JC, Glode MP, Clarke SH, Wiggins J Jr, Hathaway WE. Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of artery aneurysms. J Pediatr.\u20081984;105 :206\u2013 211","DOI":"10.1016\/S0022-3476(84)80114-6"},{"key":"2021120819410821900_R36","doi-asserted-by":"crossref","unstructured":"Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol.\u20081996;28 :253\u2013 257","DOI":"10.1016\/0735-1097(96)00099-X"},{"key":"2021120819410821900_R37","doi-asserted-by":"crossref","unstructured":"Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA.\u20081992;89 :4066\u2013 4070","DOI":"10.1073\/pnas.89.9.4066"},{"key":"2021120819410821900_R38","doi-asserted-by":"crossref","unstructured":"Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of V\u03b22+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res.\u20081996;39 :264\u2013 266","DOI":"10.1203\/00006450-199602000-00013"},{"key":"2021120819410821900_R39","doi-asserted-by":"crossref","unstructured":"Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol.\u20081995;155 :5018\u2013 5021","DOI":"10.4049\/jimmunol.155.10.5018"},{"key":"2021120819410821900_R40","doi-asserted-by":"crossref","unstructured":"Leung DY. Superantigens related to Kawasaki syndrome. Springer Semin Immunopathol.\u20081996;17 :385\u2013 396","DOI":"10.1007\/BF01795136"},{"key":"2021120819410821900_R41","doi-asserted-by":"crossref","unstructured":"Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr.\u20082002;140 :742\u2013 746","DOI":"10.1067\/mpd.2002.123664"},{"key":"2021120819410821900_R42","doi-asserted-by":"crossref","unstructured":"Rowley AH, Eckerley CA, Jack HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol.\u20081997;159 :5946\u2013 5955","DOI":"10.4049\/jimmunol.159.12.5946"},{"key":"2021120819410821900_R43","doi-asserted-by":"crossref","unstructured":"Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol.\u20082001;166 :1334\u2013 1343","DOI":"10.4049\/jimmunol.166.2.1334"},{"key":"2021120819410821900_R44","doi-asserted-by":"crossref","unstructured":"Rowley AH, Shulman ST, Mask CA, et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis.\u20082000;182 :1183\u2013 1191","DOI":"10.1086\/315832"},{"key":"2021120819410821900_R45","doi-asserted-by":"crossref","unstructured":"Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis.\u20082001;184 :940\u2013 943","DOI":"10.1086\/323155"},{"key":"2021120819410821900_R46","doi-asserted-by":"crossref","unstructured":"Takeshita S, Tokutomi T, Kawase H, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP-9) in Kawasaki disease. Clin Exp Immunol.\u20082001;125 :340\u2013 344","DOI":"10.1046\/j.1365-2249.2001.01608.x"},{"key":"2021120819410821900_R47","doi-asserted-by":"crossref","unstructured":"Yasukawa K, Terai M, Shulman ST, et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Circulation.\u20082002;105 :766\u2013 769","DOI":"10.1161\/hc0602.103396"},{"key":"2021120819410821900_R48","doi-asserted-by":"crossref","unstructured":"Maeno N, Takei S, Masuda K, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res.\u20081998;44 :596\u2013 599","DOI":"10.1203\/00006450-199810000-00021"},{"key":"2021120819410821900_R49","doi-asserted-by":"crossref","unstructured":"Asano T, Ogawa S. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy. Scand J Immunol.\u20082000;51 :98\u2013 103","DOI":"10.1046\/j.1365-3083.2000.00650.x"},{"key":"2021120819410821900_R50","doi-asserted-by":"crossref","unstructured":"Freeman AF, Crawford SE, Finn LS, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol.\u20082003;36 :102\u2013 106","DOI":"10.1002\/ppul.10333"},{"key":"2021120819410821900_R51","doi-asserted-by":"crossref","unstructured":"Eberhard BA, Andersson U, Laxer RM, Rose V, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J.\u20081995;14 :199\u2013 203","DOI":"10.1097\/00006454-199503000-00006"},{"key":"2021120819410821900_R52","doi-asserted-by":"crossref","unstructured":"Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr.\u20081994;124 :721\u2013 725","DOI":"10.1016\/S0022-3476(05)81361-7"},{"key":"2021120819410821900_R53","doi-asserted-by":"crossref","unstructured":"Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr.\u20081992;121 :924\u2013 926","DOI":"10.1016\/S0022-3476(05)80343-9"},{"key":"2021120819410821900_R54","doi-asserted-by":"crossref","unstructured":"Ohno T, Yuge T, Kariyazono H, et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr.\u20082002;161 :105\u2013 111","DOI":"10.1007\/s00431-001-0860-1"},{"key":"2021120819410821900_R55","doi-asserted-by":"crossref","unstructured":"Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn.\u20081991;41 :785\u2013 797","DOI":"10.1111\/j.1440-1827.1991.tb01620.x"},{"key":"2021120819410821900_R56","doi-asserted-by":"crossref","unstructured":"Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol.\u20082003;23 :576\u2013 581","DOI":"10.1161\/01.ATV.0000065385.47152.FD"},{"key":"2021120819410821900_R57","doi-asserted-by":"crossref","unstructured":"Suzuki A, Miyagawa-Tomita S, Komatsu K, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation.\u20082000;101 :2935\u2013 2941","DOI":"10.1161\/01.CIR.101.25.2935"},{"key":"2021120819410821900_R58","unstructured":"Kurashige M, Naoe S, Masuda H, Tanaka N. A morphological study of the digestive tract in Kawasaki disease: 31 autopsies [in Japanese]. Myakkangaku.\u20081984;24 :407\u2013 418"},{"key":"2021120819410821900_R59","doi-asserted-by":"crossref","unstructured":"Nagata S, Yamashiro Y, Maeda M, Ohtsuka Y, Yabuta K. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease. Pediatr Res.\u20081993;33 :557\u2013 563","DOI":"10.1203\/00006450-199306000-00004"},{"key":"2021120819410821900_R60","doi-asserted-by":"crossref","unstructured":"Suddleson EA, Reid B, Woolley MM, Takahashi M. Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg.\u20081987;22 :956\u2013 959","DOI":"10.1016\/S0022-3468(87)80600-0"},{"key":"2021120819410821900_R61","doi-asserted-by":"crossref","unstructured":"Tashiro N, Matsubara T, Uchida M, Katayama K, Ichiyama T, Furukawa S. Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease. Pediatrics.\u20082002;109(5) . Available at: www.pediatrics.org\/cgi\/content\/full\/109\/5\/e77","DOI":"10.1542\/peds.109.5.e77"},{"key":"2021120819410821900_R62","unstructured":"Sundel RP, Cleveland SS, Beiser AS, et al. Audiologic profiles of children with Kawasaki disease. Am J Otol.\u20081992;13 :512\u2013 515"},{"key":"2021120819410821900_R63","doi-asserted-by":"crossref","unstructured":"Knott PD, Orloff LA, Harris JP, Novak RE, Burns JC; Kawasaki Disease Multicenter Hearing Loss Study Group. Sensorineural hearing loss and Kawasaki disease: a prospective study. Am J Otolaryngol.\u20082001;22 :343\u2013 348","DOI":"10.1053\/ajot.2001.26495"},{"key":"2021120819410821900_R64","doi-asserted-by":"crossref","unstructured":"Sundel RP, Newburger JW, McGill T, et al. Sensorineural hearing loss associated with Kawasaki disease. J Pediatr.\u20081990;117 :371\u2013 377","DOI":"10.1016\/S0022-3476(05)81075-3"},{"key":"2021120819410821900_R65","doi-asserted-by":"crossref","unstructured":"Zulian F, Falcini F, Zancan L, et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J Pediatr.\u20082003;142 :731\u2013 735","DOI":"10.1067\/mpd.2003.232"},{"key":"2021120819410821900_R66","doi-asserted-by":"crossref","unstructured":"Kuniyuki S, Asada M. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol.\u20081997;37 :303\u2013 304","DOI":"10.1016\/S0190-9622(97)80376-3"},{"key":"2021120819410821900_R67","doi-asserted-by":"crossref","unstructured":"Uziel Y, Hashkes PJ, Kassem E, Gottesman G, Wolach B. \u201cUnresolving pneumonia\u201d as the main manifestation of atypical Kawasaki disease. Arch Dis Child.\u20082003;88 :940\u2013 942","DOI":"10.1136\/adc.88.10.940"},{"key":"2021120819410821900_R68","doi-asserted-by":"crossref","unstructured":"Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J.\u20082003;22 :663\u2013 666","DOI":"10.1097\/01.inf.0000073061.55674.1b"},{"key":"2021120819410821900_R69","doi-asserted-by":"crossref","unstructured":"Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr.\u20081992;120 :926\u2013 928","DOI":"10.1016\/S0022-3476(05)81964-X"},{"key":"2021120819410821900_R70","doi-asserted-by":"crossref","unstructured":"Shulman ST. Hemolysis in Kawasaki disease. Transfusion.\u20081991;31 :572","DOI":"10.1046\/j.1537-2995.1991.31691306257.x"},{"key":"2021120819410821900_R71","doi-asserted-by":"crossref","unstructured":"Bunin NJ, Carey JL, Sullivan DB. Autoimmune hemolytic anemia in association with Kawasaki disease. Am J Pediatr Hematol Oncol.\u20081986;8 :351\u2013 353","DOI":"10.1097\/00043426-198624000-00019"},{"key":"2021120819410821900_R72","doi-asserted-by":"crossref","unstructured":"Hillyer CD, Schwenn MR, Fulton DR, Meissner HC, Berkman EM. Autoimmune hemolytic anemia in Kawasaki disease: a case report. Transfusion.\u20081990;30 :738\u2013 740","DOI":"10.1046\/j.1537-2995.1990.30891020336.x"},{"key":"2021120819410821900_R73","doi-asserted-by":"crossref","unstructured":"Andersson MS, Burns J, Treadwell TA, Pietra BA, Glode MP. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J.\u20082001;20 :698\u2013 702","DOI":"10.1097\/00006454-200107000-00011"},{"key":"2021120819410821900_R74","doi-asserted-by":"crossref","unstructured":"Hicks RV, Melish ME. Kawasaki syndrome. Pediatr Clin North Am.\u20081986;33 :1151\u2013 1175","DOI":"10.1016\/S0031-3955(16)36113-2"},{"key":"2021120819410821900_R75","doi-asserted-by":"crossref","unstructured":"Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation.\u20081991;84 :625\u2013 631","DOI":"10.1161\/01.CIR.84.2.625"},{"key":"2021120819410821900_R76","doi-asserted-by":"crossref","unstructured":"Salo E, Pesonen E, Viikari J. Serum cholesterol levels during and after Kawasaki disease. J Pediatr.\u20081991;119 :557\u2013 561","DOI":"10.1016\/S0022-3476(05)82404-7"},{"key":"2021120819410821900_R77","doi-asserted-by":"crossref","unstructured":"Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res.\u20081997;42 :651\u2013 655","DOI":"10.1203\/00006450-199711000-00017"},{"key":"2021120819410821900_R78","doi-asserted-by":"crossref","unstructured":"Okada T, Harada K, Okuni M. Serum HDL-cholesterol and lipoprotein fraction in Kawasaki disease (acute mucocutaneous lymph node syndrome). Jpn Circ J.\u20081982;46 :1039\u2013 1044","DOI":"10.1253\/jcj.46.1039"},{"key":"2021120819410821900_R79","doi-asserted-by":"crossref","unstructured":"Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr.\u20081991;118 :680\u2013 686","DOI":"10.1016\/S0022-3476(05)80026-5"},{"key":"2021120819410821900_R80","doi-asserted-by":"crossref","unstructured":"Ting EC, Capparelli EV, Billman GF, Lavine JE, Matsubara T, Burns JC. Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease. Pediatr Infect Dis J.\u20081998;17 :431\u2013 432","DOI":"10.1097\/00006454-199805000-00020"},{"key":"2021120819410821900_R81","doi-asserted-by":"crossref","unstructured":"Dengler LD, Capparelli EV, Bastian JF, et al. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Pediatr Infect Dis J.\u20081998;17 :478\u2013 481","DOI":"10.1097\/00006454-199806000-00008"},{"key":"2021120819410821900_R82","doi-asserted-by":"crossref","unstructured":"Kim M, Kim K. Changes in cardiac troponin I in Kawasaki disease before and after treatment with intravenous gammaglobulin. Jpn Circ J.\u20081998;62 :479\u2013 482","DOI":"10.1253\/jcj.62.479"},{"key":"2021120819410821900_R83","doi-asserted-by":"crossref","unstructured":"Kim M, Kim K. Elevation of cardiac troponin I in the acute stage of Kawasaki disease. Pediatr Cardiol.\u20081999;20 :184\u2013 188","DOI":"10.1007\/s002469900437"},{"key":"2021120819410821900_R84","doi-asserted-by":"crossref","unstructured":"Checchia PA, Borensztajn J, Shulman ST. Circulating cardiac troponin I levels in Kawasaki disease. Pediatr Cardiol.\u20082001;22 :102\u2013 106","DOI":"10.1007\/s002460010170"},{"key":"2021120819410821900_R85","doi-asserted-by":"crossref","unstructured":"Burns JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr.\u20081986;109 :759\u2013 763","DOI":"10.1016\/S0022-3476(86)80689-8"},{"key":"2021120819410821900_R86","unstructured":"Asai T. Diagnosis and prognosis of coronary artery lesions in Kawasaki disease. Coronary angiography and the conditions for its application (a score chart) [in Japanese]. Nippon Rinsho.\u20081983;41 :2080\u2013 2085"},{"key":"2021120819410821900_R87","doi-asserted-by":"crossref","unstructured":"Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr.\u20081986;108 :388\u2013 392","DOI":"10.1016\/S0022-3476(86)80878-2"},{"key":"2021120819410821900_R88","doi-asserted-by":"crossref","unstructured":"Ichida F, Fatica NS, Engle MA, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Pediatrics.\u20081987;80 :828\u2013 835","DOI":"10.1542\/peds.80.6.828"},{"key":"2021120819410821900_R89","doi-asserted-by":"crossref","unstructured":"Daniels SR, Specker B, Capannari TE, Schwartz DC, Burke MJ, Kaplan S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am J Dis Child.\u20081987;141 :205\u2013 207","DOI":"10.1001\/archpedi.1987.04460020095035"},{"key":"2021120819410821900_R90","unstructured":"Harada K, Yamaguchi H, Kato H, et al. Indication for intravenous gamma globulin treatment for Kawasaki disease. In: Takahashi M, Taubert K, eds. Proceedings of the Fourth International Symposium on Kawasaki Disease. Dallas, TX: American Heart Association; 1993:459\u2013462"},{"key":"2021120819410821900_R91","doi-asserted-by":"crossref","unstructured":"Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn.\u20081991;33 :805\u2013 810","DOI":"10.1111\/j.1442-200X.1991.tb02612.x"},{"key":"2021120819410821900_R92","doi-asserted-by":"crossref","unstructured":"Beiser AS, Takahasha M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. Am J Cardiol.\u20081998;81 :1116\u2013 1120","DOI":"10.1016\/S0002-9149(98)00116-7"},{"key":"2021120819410821900_R93","doi-asserted-by":"crossref","unstructured":"Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics.\u20081999;104(1) . Available at: www.pediatrics.org\/cgi\/content\/full\/104\/1\/e10","DOI":"10.1542\/peds.104.1.e10"},{"key":"2021120819410821900_R94","unstructured":"Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med.\u20081995;162 :322\u2013 327"},{"key":"2021120819410821900_R95","unstructured":"Tseng CF, Fu YC, Fu LS, Betau H, Chi CS. Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi.\u20082001;64 :168\u2013 173"},{"key":"2021120819410821900_R96","doi-asserted-by":"crossref","unstructured":"de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr.\u20081998;133 :254\u2013 258","DOI":"10.1016\/S0022-3476(98)70229-X"},{"key":"2021120819410821900_R97","doi-asserted-by":"crossref","unstructured":"Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int.\u20082002;44 :1\u2013 4","DOI":"10.1046\/j.1442-200X.2002.01508.x"},{"key":"2021120819410821900_R98","doi-asserted-by":"crossref","unstructured":"Dajani AS, Taubert KA, Takahashi M, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation.\u20081994;89 :916\u2013 922","DOI":"10.1161\/01.CIR.89.2.916"},{"key":"2021120819410821900_R99","unstructured":"Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984"},{"key":"2021120819410821900_R100","doi-asserted-by":"crossref","unstructured":"Ravekes WJ, Colan SD, Gauvreau K, et al. Aortic root dilation in Kawasaki disease. Am J Cardiol.\u20082001;87 :919\u2013 922","DOI":"10.1016\/S0002-9149(00)01541-1"},{"key":"2021120819410821900_R101","doi-asserted-by":"crossref","unstructured":"Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics.\u20081999;104(5) . Available at: www.pediatrics.org\/cgi\/content\/full\/104\/5\/e57","DOI":"10.1542\/peds.104.5.e57"},{"key":"2021120819410821900_R102","doi-asserted-by":"crossref","unstructured":"McMorrow Tuohy AM, Tani LY, Cetta F, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol.\u20082001;88 :328\u2013 330","DOI":"10.1016\/S0002-9149(01)01655-1"},{"key":"2021120819410821900_R103","doi-asserted-by":"crossref","unstructured":"Dhillon R, Clarkson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation.\u20081996;94 :2103\u2013 2106","DOI":"10.1161\/01.CIR.94.9.2103"},{"key":"2021120819410821900_R104","doi-asserted-by":"crossref","unstructured":"Kurisu Y, Azumi T, Sugahara T, Igarashi Y, Takamiya M, Kozuka T. Variation in coronary arterial dimension (distensible abnormality) after disappearing aneurysm in Kawasaki disease. Am Heart J.\u20081987;114 :532\u2013 538","DOI":"10.1016\/0002-8703(87)90749-6"},{"key":"2021120819410821900_R105","unstructured":"Mitani Y, Okuda Y, Shimpo H, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation.\u20081997;96 :454\u2013 461"},{"key":"2021120819410821900_R106","doi-asserted-by":"crossref","unstructured":"Muzik O, Paridon SM, Singh TP, Morrow WR, Dayanikli F, DiCarli MF. Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography. J Am Coll Cardiol.\u20081996;28 :757\u2013 762","DOI":"10.1016\/0735-1097(96)00199-4"},{"key":"2021120819410821900_R107","doi-asserted-by":"crossref","unstructured":"Duerinckx A, Troutman B, Allada V, Kim D. Coronary MR angiography in Kawasaki disease. AJR Am J Roentgenol.\u20081997;168 :114\u2013 116","DOI":"10.2214\/ajr.168.1.8976932"},{"key":"2021120819410821900_R108","doi-asserted-by":"crossref","unstructured":"Sakuma H, Goto M, Nomura Y, Kato N, Takeda K, Higgins CB. Three-dimensional coronary magnetic resonance angiography with injection of extracellular contrast medium. Invest Radiol.\u20081999;34 :503\u2013 508","DOI":"10.1097\/00004424-199908000-00002"},{"key":"2021120819410821900_R109","doi-asserted-by":"crossref","unstructured":"Danias PG, Stuber M, Botnar RM, et al. Coronary MR angiography clinical applications and potential for imaging coronary artery disease. Magn Reson Imaging Clin N Am.\u20082003;11 :81\u2013 99","DOI":"10.1016\/S1064-9689(02)00022-3"},{"key":"2021120819410821900_R110","doi-asserted-by":"crossref","unstructured":"Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation.\u20082002;105 :908\u2013 911","DOI":"10.1161\/hc0802.105563"},{"key":"2021120819410821900_R111","doi-asserted-by":"crossref","unstructured":"Frey EE, Matherne GP, Mahoney LT, Sato Y, Stanford W, Smith WL. Coronary artery aneurysms due to Kawasaki disease: diagnosis with ultrafast CT. Radiology.\u20081988;167 :725\u2013 726","DOI":"10.1148\/radiology.167.3.3363129"},{"key":"2021120819410821900_R112","doi-asserted-by":"crossref","unstructured":"Sato Y, Kato M, Inoue F, et al. Detection of coronary artery aneurysms, stenoses and occlusions by multislice spiral computed tomography in adolescents with kawasaki disease. Circ J.\u20082003;67 :427\u2013 430","DOI":"10.1253\/circj.67.427"},{"key":"2021120819410821900_R113","doi-asserted-by":"crossref","unstructured":"Kondo C, Hiroe M, Nakanishi T, Takao A. Detection of coronary artery stenosis in children with Kawasaki disease. Circulation.\u20081989;80 :615\u2013 624","DOI":"10.1161\/01.CIR.80.3.615"},{"key":"2021120819410821900_R114","doi-asserted-by":"crossref","unstructured":"Jan SL, Hwang B, Fu YC, et al. Usefulness of pharmacologic stress 201Tl myocardial tomography. Comparison of 201Tl SPET and treadmill exercise testing in patients with Kawasaki disease. Nucl Med Commun.\u20082000;21 :431\u2013 435","DOI":"10.1097\/00006231-200005000-00004"},{"key":"2021120819410821900_R115","doi-asserted-by":"crossref","unstructured":"Pahl E, Sehgal R, Chrystof D, et al. Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease. Circulation.\u20081995;91 :122\u2013 128","DOI":"10.1161\/01.CIR.91.1.122"},{"key":"2021120819410821900_R116","doi-asserted-by":"crossref","unstructured":"Henein MY, Dinarevic S, O'Sullivan CA, Gibson DG, Shinebourne EA. Exercise echocardiography in children with Kawasaki disease: ventricular long axis is selectively abnormal. Am J Cardiol.\u20081998;81 :1356\u2013 1359","DOI":"10.1016\/S0002-9149(98)00168-4"},{"key":"2021120819410821900_R117","doi-asserted-by":"crossref","unstructured":"Noto N, Ayusawa M, Karasawa K, et al. Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. J Am Coll Cardiol.\u20081996;27 :1251\u2013 1256","DOI":"10.1016\/0735-1097(95)00570-6"},{"key":"2021120819410821900_R118","doi-asserted-by":"crossref","unstructured":"Kimball TR, Witt SA, Daniels SR. Dobutamine stress echocardiography in the assessment of suspected myocardial ischemia in children and young adults. Am J Cardiol.\u20081997;79 :380\u2013 384","DOI":"10.1016\/S0002-9149(97)89286-7"},{"key":"2021120819410821900_R119","unstructured":"Bezold LI, Lewin MB, Vick GW III, Pignatelli R. Update on new technologies in pediatric echocardiography. Tex Heart Inst J.\u20081997;24 :278\u2013 286"},{"key":"2021120819410821900_R120","doi-asserted-by":"crossref","unstructured":"Muhling O, Jerosch-Herold M, Nabauer M, Wilke N. Assessment of ischemic heart disease using magnetic resonance first-pass perfusion imaging. Herz.\u20082003;28 :82\u2013 89","DOI":"10.1007\/s00059-003-2458-z"},{"key":"2021120819410821900_R121","doi-asserted-by":"crossref","unstructured":"Kaul S, Ito H. Microvasculature in acute myocardial ischemia: part I: evolving concepts in pathophysiology, diagnosis, and treatment. Circulation.\u20082004;109 :146\u2013 149","DOI":"10.1161\/01.CIR.0000111582.02736.CD"},{"key":"2021120819410821900_R122","doi-asserted-by":"crossref","unstructured":"Zilberman MV, Witt SA, Kimball TR. Is there a role for intravenous transpulmonary contrast imaging in pediatric stress echocardiography? J Am Soc Echocardiogr.\u20082003;16 :9\u2013 14","DOI":"10.1067\/mje.2003.41"},{"key":"2021120819410821900_R123","doi-asserted-by":"crossref","unstructured":"Ishii M, Himeno W, Sawa M, et al. Assessment of the ability of myocardial contrast echocardiography with harmonic power Doppler imaging to identify perfusion abnormalities in patients with Kawasaki disease at rest and during dipyridamole stress. Pediatr Cardiol.\u20082002;23 :192\u2013 199","DOI":"10.1007\/s00246-001-0046-7"},{"key":"2021120819410821900_R124","doi-asserted-by":"crossref","unstructured":"Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation.\u20081994;89 :258\u2013 265","DOI":"10.1161\/01.CIR.89.1.258"},{"key":"2021120819410821900_R125","doi-asserted-by":"crossref","unstructured":"Matsumura K, Okuda Y, Ito T, Hirano T, Takeda K, Yamaguchi M. Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. Angiology.\u20081988;39 :141\u2013 147","DOI":"10.1177\/000331978803900203"},{"key":"2021120819410821900_R126","doi-asserted-by":"crossref","unstructured":"Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr.\u20081992;121 :684\u2013 688","DOI":"10.1016\/S0022-3476(05)81893-1"},{"key":"2021120819410821900_R127","doi-asserted-by":"crossref","unstructured":"Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol.\u20081986;7 :3\u2013 9","DOI":"10.1007\/BF02315475"},{"key":"2021120819410821900_R128","doi-asserted-by":"crossref","unstructured":"Yutani C, Okano K, Kamiya T, et al. Histopathological study on right endomyocardial biopsy of Kawasaki disease. Br Heart J.\u20081980;43 :589\u2013 592","DOI":"10.1136\/hrt.43.5.589"},{"key":"2021120819410821900_R129","doi-asserted-by":"crossref","unstructured":"Matsuura H, Ishikita T, Yamamoto S, et al. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography. Br Heart J.\u20081987;58 :385\u2013 392","DOI":"10.1136\/hrt.58.4.385"},{"key":"2021120819410821900_R130","doi-asserted-by":"crossref","unstructured":"Klassen TP, Rowe PC, Gafni A. Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome. J Pediatr.\u20081993;122 :538\u2013 542","DOI":"10.1016\/S0022-3476(05)83532-2"},{"key":"2021120819410821900_R131","doi-asserted-by":"crossref","unstructured":"Kao CH, Hsieh KS, Wang YL, et al. Tc-99m HMPAO labeled WBC scan for the detection of myocarditis in different phases of Kawasaki disease. Clin Nucl Med.\u20081992;17 :185\u2013 190","DOI":"10.1097\/00003072-199203000-00006"},{"key":"2021120819410821900_R132","doi-asserted-by":"crossref","unstructured":"Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology.\u20081991;75 :388\u2013 393","DOI":"10.1097\/00000542-199109000-00002"},{"key":"2021120819410821900_R133","doi-asserted-by":"crossref","unstructured":"Anderson TM, Meyer RA, Kaplan S. Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J.\u20081985;110 :107\u2013 115","DOI":"10.1016\/0002-8703(85)90523-X"},{"key":"2021120819410821900_R134","doi-asserted-by":"crossref","unstructured":"Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol.\u20081981;47 :323\u2013 330","DOI":"10.1016\/0002-9149(81)90404-5"},{"key":"2021120819410821900_R135","doi-asserted-by":"crossref","unstructured":"Moran AM, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J.\u20082000;139 :217\u2013 223","DOI":"10.1016\/S0002-8703(00)90229-1"},{"key":"2021120819410821900_R136","unstructured":"Yutani C, Go S, Kamiya T, et al. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med.\u20081981;105 :470\u2013 473"},{"key":"2021120819410821900_R137","unstructured":"Takahashi M, Shimada H, Billingham ME, Mason W, Miller JH. Electron microscopic findings of myocardial biopsy correlated with perfusion scan and coronary angiography in chronic Kawasaki syndrome: myocellular ischemia possibly due to microvasculopathy. In: Kato H, ed. Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22\u201325, 1995. New York, NY: Elsevier Science; 1995:401\u2013410"},{"key":"2021120819410821900_R138","unstructured":"Gidding SS. Late onset valvular dysfunction in Kawasaki disease. Prog Clin Biol Res.\u20081987;250 :305\u2013 309"},{"key":"2021120819410821900_R139","doi-asserted-by":"crossref","unstructured":"Nakano H, Nojima K, Saito A, Ueda K. High incidence of aortic regurgitation following Kawasaki disease. J Pediatr.\u20081985;107 :59\u2013 63","DOI":"10.1016\/S0022-3476(85)80615-6"},{"key":"2021120819410821900_R140","doi-asserted-by":"crossref","unstructured":"Gidding SS, Shulman ST, Ilbawi M, Crussi F, Duffy CE. Mucocutaneous lymph node syndrome (Kawasaki disease): delayed aortic and mitral insufficiency secondary to active valvulitis. J Am Coll Cardiol.\u20081986;7 :894\u2013 897","DOI":"10.1016\/S0735-1097(86)80354-0"},{"key":"2021120819410821900_R141","doi-asserted-by":"crossref","unstructured":"Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics.\u20081995;96 :1057\u2013 1061","DOI":"10.1542\/peds.96.6.1057"},{"key":"2021120819410821900_R142","doi-asserted-by":"crossref","unstructured":"Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med.\u20082001;345 :1809\u2013 1817","DOI":"10.1056\/NEJMoa003199"},{"key":"2021120819410821900_R143","unstructured":"Takahashi M, Mason W, Thomas D, Sinatra F. Reye syndrome following Kawasaki syndrome confirmed by liver histopathology. In: Kato H, ed. Kawasaki Diseas. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22\u201325, 1995. New York, NY: Elsevier Science; 1995:436\u2013444"},{"key":"2021120819410821900_R144","unstructured":"Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi.\u20081992;33 :67\u2013 71"},{"key":"2021120819410821900_R145","unstructured":"Pickering LK, ed. Red Book. 2003 Report of the Committee on Infectious Diseases. Chicago, IL: American Academy of Pediatrics; 2003"},{"key":"2021120819410821900_R146","doi-asserted-by":"crossref","unstructured":"Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet.\u20081984;2 :1055\u2013 1058","DOI":"10.1016\/S0140-6736(84)91504-6"},{"key":"2021120819410821900_R147","doi-asserted-by":"crossref","unstructured":"Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med.\u20081986;315 :341\u2013 347","DOI":"10.1056\/NEJM198608073150601"},{"key":"2021120819410821900_R148","doi-asserted-by":"crossref","unstructured":"Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr.\u20081997;131 :888\u2013 893","DOI":"10.1016\/S0022-3476(97)70038-6"},{"key":"2021120819410821900_R149","doi-asserted-by":"crossref","unstructured":"Sawaji Y, Haneda N, Yamaguchi S, et al. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications. Acta Paediatr Jpn.\u20081998;40 :218\u2013 225","DOI":"10.1111\/j.1442-200X.1998.tb01915.x"},{"key":"2021120819410821900_R150","doi-asserted-by":"crossref","unstructured":"Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr.\u20082004;144 :496\u2013 499","DOI":"10.1016\/j.jpeds.2003.12.033"},{"key":"2021120819410821900_R151","doi-asserted-by":"crossref","unstructured":"Fong NC, Hui YW, Li CK, Chiu MC. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol.\u20082004;25 :31\u2013 34","DOI":"10.1007\/s00246-003-0558-4"},{"key":"2021120819410821900_R152","doi-asserted-by":"crossref","unstructured":"Marasini M, Pongiglione G, Gazzolo D, Campelli A, Ribaldone D, Caponnetto S. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol.\u20081991;68 :796\u2013 797","DOI":"10.1016\/0002-9149(91)90658-8"},{"key":"2021120819410821900_R153","doi-asserted-by":"crossref","unstructured":"Rosenfeld EA, Shulman ST, Corydon KE, Mason W, Takahashi M, Kuroda C. Comparative safety and efficacy of two immune globulin products in Kawasaki disease. J Pediatr.\u20081995;126 :1000\u2013 1003","DOI":"10.1016\/S0022-3476(95)70233-4"},{"key":"2021120819410821900_R154","unstructured":"Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States. October 1993-June 1994. MMWR Morb Mortal Wkly Rep.\u20081994;43 :505\u2013 509"},{"key":"2021120819410821900_R155","doi-asserted-by":"crossref","unstructured":"Venglarcik JS III, Ayas M, Woods T. Severe thrombocytopenia as a presenting manifestation of Kawasaki disease. Arch Pediatr Adolesc Med.\u20081995;149 :215\u2013 217","DOI":"10.1001\/archpedi.1995.02170140097019"},{"key":"2021120819410821900_R156","doi-asserted-by":"crossref","unstructured":"Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J.\u20081998;17 :1144\u2013 1148","DOI":"10.1097\/00006454-199812000-00009"},{"key":"2021120819410821900_R157","unstructured":"Silverman ED, Huang C, Rose V, et al. IVGG treatment of Kawasaki disease: are all brands equal? In: Kato H, ed. Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22\u201325, 1995. New York, NY: Elsevier Science; 1995:301\u2013304"},{"key":"2021120819410821900_R158","doi-asserted-by":"crossref","unstructured":"Shulman ST. Is there a role for corticosteroids in Kawasaki disease? J Pediatr.\u20082003;142 :601\u2013 603","DOI":"10.1067\/mpd.2003.258"},{"key":"2021120819410821900_R159","doi-asserted-by":"crossref","unstructured":"Kato H, Koike S, Yokoyama T. Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics.\u20081979;63 :175\u2013 179","DOI":"10.1542\/peds.63.2.175"},{"key":"2021120819410821900_R160","doi-asserted-by":"crossref","unstructured":"Kijima Y, Kamiya T, Suzuki A, Hirose O, Manabe H. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Jpn Circ J.\u20081982;46 :1239\u2013 1242","DOI":"10.1253\/jcj.46.1239"},{"key":"2021120819410821900_R161","unstructured":"Nonaka Z, Maekawa K, Okabe T, Eto Y, Kubo M. Randomized controlled study of intravenous prednisolone and gamma globulin treatment in 100 cases with Kawasaki disease. In: Kato H, ed. Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22\u201325, 1995. New York, NY: Elsevier Science; 1995:328\u2013331"},{"key":"2021120819410821900_R162","doi-asserted-by":"crossref","unstructured":"Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr.\u20081999;135 :465\u2013 469","DOI":"10.1016\/S0022-3476(99)70169-1"},{"key":"2021120819410821900_R163","doi-asserted-by":"crossref","unstructured":"Sundel RP, Baker AL, Fulton DR, Newburger JW. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr.\u20082003;142 :611\u2013 616","DOI":"10.1067\/mpd.2003.191"},{"key":"2021120819410821900_R164","doi-asserted-by":"crossref","unstructured":"Okada Y, Shinohara M, Kobayashi T, et al. Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J Pediatr.\u20082003;143 :363\u2013 367","DOI":"10.1067\/S0022-3476(03)00387-1"},{"key":"2021120819410821900_R165","doi-asserted-by":"crossref","unstructured":"Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K. Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr.\u20081994;153 :663\u2013 667","DOI":"10.1007\/BF02190688"},{"key":"2021120819410821900_R166","doi-asserted-by":"crossref","unstructured":"Best BM, Burns JC, DeVincenzo J, et al. Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in Kawasaki disease. Curr Ther Res Clin Exp.\u20082003;64 :96\u2013 115","DOI":"10.1016\/S0011-393X(03)00018-3"},{"key":"2021120819410821900_R167","doi-asserted-by":"crossref","unstructured":"Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol.\u20082003;24 :145\u2013 148","DOI":"10.1007\/s00246-002-0216-2"},{"key":"2021120819410821900_R168","doi-asserted-by":"crossref","unstructured":"Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics.\u20082000;105(6) . Available at: www.pediatrics.org\/cgi\/content\/full\/105\/6\/e78","DOI":"10.1542\/peds.105.6.e78"},{"key":"2021120819410821900_R169","doi-asserted-by":"crossref","unstructured":"Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr.\u20081996;128 :146\u2013 149","DOI":"10.1016\/S0022-3476(96)70447-X"},{"key":"2021120819410821900_R170","doi-asserted-by":"crossref","unstructured":"Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr.\u20082000;137 :723\u2013 726","DOI":"10.1067\/mpd.2000.108444"},{"key":"2021120819410821900_R171","doi-asserted-by":"crossref","unstructured":"Hashino K, Ishii M, Iemura M, Akagi T, Kato H. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int.\u20082001;43 :211\u2013 217","DOI":"10.1046\/j.1442-200x.2001.01373.x"},{"key":"2021120819410821900_R172","doi-asserted-by":"crossref","unstructured":"Imagawa T, Mori M, Miyamae T, et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr.\u20082004;163 :263\u2013 264","DOI":"10.1007\/s00431-003-1267-y"},{"key":"2021120819410821900_R173","doi-asserted-by":"crossref","unstructured":"Takagi N, Kihara M, Yamaguchi S, et al. Plasma exchange in Kawasaki disease. Lancet.\u20081995;346 :1307","DOI":"10.1016\/S0140-6736(95)91916-3"},{"key":"2021120819410821900_R174","unstructured":"Villain E, Kachaner J, Sidi D, Blaysat G, Piechaud JF, Pedroni E. Trial of prevention of coronary aneurysm in Kawasaki's disease using plasma exchange or infusion of immunoglobulins [in French]. Arch Fr Pediatr.\u20081987;44 :79\u2013 83"},{"key":"2021120819410821900_R175","doi-asserted-by":"crossref","unstructured":"Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, Tasaki H, Miyazaki S. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis.\u20082000;181 :1101\u2013 1109","DOI":"10.1086\/315332"},{"key":"2021120819410821900_R176","doi-asserted-by":"crossref","unstructured":"Williams RV, Wilke VM, Tani LY, Minich LL. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics.\u20082002;109(1) . Available at: www.pediatrics.org\/cgi\/content\/full\/109\/1\/e4","DOI":"10.1542\/peds.109.1.e4"},{"key":"2021120819410821900_R177","unstructured":"Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Infliximab as a novel therapy for refractory Kawasaki disease. J Rheumatol.\u20082004;31 :808\u2013 810"},{"key":"2021120819410821900_R178","doi-asserted-by":"crossref","unstructured":"Kuijpers TW, Biezeveld M, Achterhuis A, et al. Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect. Pediatrics.\u20082003;112 :986\u2013 992","DOI":"10.1542\/peds.112.4.986"},{"key":"2021120819410821900_R179","doi-asserted-by":"crossref","unstructured":"Gerschutz GP, Bhatt DL. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable? Am Heart J.\u20082003;145 :595\u2013 601","DOI":"10.1067\/mhj.2003.180"},{"key":"2021120819410821900_R180","doi-asserted-by":"crossref","unstructured":"Peters RJ, Mehta SR, Fox KA, et al. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation.\u20082003;108 :1682\u2013 1687","DOI":"10.1161\/01.CIR.0000091201.39590.CB"},{"key":"2021120819410821900_R181","doi-asserted-by":"crossref","unstructured":"Albers GW, Amarenco P. Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascular patients? Stroke.\u20082001;32 :2948\u2013 2949","DOI":"10.1161\/hs1201.100829"},{"key":"2021120819410821900_R182","doi-asserted-by":"crossref","unstructured":"Mehta SR, Yusuf S. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J.\u20082000;21 :2033\u2013 2041","DOI":"10.1053\/euhj.2000.2474"},{"key":"2021120819410821900_R183","doi-asserted-by":"crossref","unstructured":"Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int.\u20082000;42 :470\u2013 475","DOI":"10.1046\/j.1442-200x.2000.01270.x"},{"key":"2021120819410821900_R184","unstructured":"Burtt DM, Pollack P, Bianco JA. Intravenous streptokinase in an infant with Kawasaki's disease complicated by acute myocardial infarction. Pediatr Cardiol.\u20081986;6 :307\u2013 311"},{"key":"2021120819410821900_R185","unstructured":"Cheatham JP, Kugler JD, Gumbiner CH, Latson LA, Hofschire PJ. Intracoronary streptokinase in Kawasaki disease: acute and thrombolysis. Prog Clin Biol Res.\u20081987;250 :517\u2013 518"},{"key":"2021120819410821900_R186","doi-asserted-by":"crossref","unstructured":"Katayama F, Hiraishi S, Takeda N, Misawa H. Intracoronary urokinase and post-thrombolytic regimen in an infant with Kawasaki disease and acute myocardial infarction. Heart.\u20081997;78 :621\u2013 622","DOI":"10.1136\/hrt.78.6.621"},{"key":"2021120819410821900_R187","unstructured":"Kato H, Ichinose E, Inoue O, Akagi T. Intracoronary thrombolytic therapy in Kawasaki disease: treatment and prevention of acute myocardial infarction. Prog Clin Biol Res.\u20081987;250 :445\u2013 454"},{"key":"2021120819410821900_R188","doi-asserted-by":"crossref","unstructured":"Terai M, Ogata M, Sugimoto K, et al. Coronary arterial thrombi in Kawasaki disease. J Pediatr.\u20081985;106 :76\u2013 78","DOI":"10.1016\/S0022-3476(85)80471-6"},{"key":"2021120819410821900_R189","doi-asserted-by":"crossref","unstructured":"Horigome H, Sekijima T, Miyamoto T. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart.\u20081997;78 :517\u2013 518","DOI":"10.1136\/hrt.78.5.517"},{"key":"2021120819410821900_R190","doi-asserted-by":"crossref","unstructured":"Levy M, Benson LN, Burrows PE, et al. Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr.\u20081991;118 :467\u2013 472","DOI":"10.1016\/S0022-3476(05)82170-5"},{"key":"2021120819410821900_R191","doi-asserted-by":"crossref","unstructured":"Lange RA, Hillis LD. Reperfusion therapy in acute myocardial infarction. N Engl J Med.\u20082002;346 :954\u2013 955","DOI":"10.1056\/NEJM200203283461302"},{"key":"2021120819410821900_R192","doi-asserted-by":"crossref","unstructured":"Maggioni AP, Franzosi MG, Fresco C, Turazza F, Tognoni G. GISSI trials in acute myocardial infarction. Rationale, design, and results. Chest.\u20081990;97 :146S\u2013 150S","DOI":"10.1378\/chest.97.4_Supplement.146S"},{"key":"2021120819410821900_R193","doi-asserted-by":"crossref","unstructured":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet.\u20081988;2 :349\u2013 360","DOI":"10.1016\/S0140-6736(88)92833-4"},{"key":"2021120819410821900_R194","doi-asserted-by":"crossref","unstructured":"Ridker PM, O'Donnell C, Marder VJ, Hennekens CH. Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Intern Med.\u20081993;119 :530\u2013 532","DOI":"10.7326\/0003-4819-119-6-199309150-00017"},{"key":"2021120819410821900_R195","unstructured":"Hennekens CH. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1. Clin Cardiol.\u20081994;17 :I15\u2013 I17"},{"key":"2021120819410821900_R196","doi-asserted-by":"crossref","unstructured":"Newby LK, Rutsch WR, Califf RM, et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol.\u20081996;27 :1646\u2013 1655","DOI":"10.1016\/0735-1097(96)00053-8"},{"key":"2021120819410821900_R197","doi-asserted-by":"crossref","unstructured":"Wang-Clow F, Fox NL, Cannon CP, et al. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator. Am Heart J.\u20082001;141 :33\u2013 40","DOI":"10.1067\/mhj.2001.112092"},{"key":"2021120819410821900_R198","doi-asserted-by":"crossref","unstructured":"Westerhout CM, Boersma E. Risk-benefit analysis of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes. Expert Opin Drug Saf.\u20082003;2 :49\u2013 58","DOI":"10.1517\/14740338.2.1.49"},{"key":"2021120819410821900_R199","doi-asserted-by":"crossref","unstructured":"Ibbotson T, McGavin JK, Goa KL. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation. Drugs.\u20082003;63 :1121\u2013 1163","DOI":"10.2165\/00003495-200363110-00014"},{"key":"2021120819410821900_R200","doi-asserted-by":"crossref","unstructured":"Hellstrom HR. Platelet glycoprotein IIb\/IIIa inhibitors. Circulation.\u20082003;107 :E39","DOI":"10.1161\/01.CIR.0000053955.01455.5A"},{"key":"2021120819410821900_R201","doi-asserted-by":"crossref","unstructured":"Kitamura S, Kameda Y, Seki T, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg.\u20081994;107 :663\u2013 674","DOI":"10.1016\/S0022-5223(94)70321-3"},{"key":"2021120819410821900_R202","doi-asserted-by":"crossref","unstructured":"Tsuda E, Kitamura S; Cooperative Study Group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation.\u20082004;110 :II61\u2013 II66","DOI":"10.1161\/01.CIR.0000138194.61225.10"},{"key":"2021120819410821900_R203","doi-asserted-by":"crossref","unstructured":"Yoshikawa Y, Yagihara T, Kameda Y, et al. Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease. Eur J Cardiothorac Surg.\u20082000;17 :515\u2013 519","DOI":"10.1016\/S1010-7940(00)00355-9"},{"key":"2021120819410821900_R204","doi-asserted-by":"crossref","unstructured":"Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Subcommittee of Cardiovascular Sequelae, Subcommittee of Surgical Treatment, Kawasaki Disease Research Committee. Heart Vessels.\u20081987;3 :50\u2013 54","DOI":"10.1007\/BF02073648"},{"key":"2021120819410821900_R205","doi-asserted-by":"crossref","unstructured":"Kitamura S. The role of coronary bypass operation on children with Kawasaki disease. Coron Artery Dis.\u20082002;13 :437\u2013 447","DOI":"10.1097\/00019501-200212000-00009"},{"key":"2021120819410821900_R206","doi-asserted-by":"crossref","unstructured":"Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr.\u20081986;108 :923\u2013 927","DOI":"10.1016\/S0022-3476(86)80928-3"},{"key":"2021120819410821900_R207","doi-asserted-by":"crossref","unstructured":"Ino T, Akimoto K, Ohkubo M, et al. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation.\u20081996;93 :1709\u2013 1715","DOI":"10.1161\/01.CIR.93.9.1709"},{"key":"2021120819410821900_R208","doi-asserted-by":"crossref","unstructured":"Sugimura T, Yokoi H, Sato N, et al. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation.\u20081997;96 :3928\u2013 3933","DOI":"10.1161\/01.CIR.96.11.3928"},{"key":"2021120819410821900_R209","doi-asserted-by":"crossref","unstructured":"Ishii M, Ueno T, Akagi T, et al. Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int.\u20082001;43 :558\u2013 562","DOI":"10.1046\/j.1442-200X.2001.01464.x"},{"key":"2021120819410821900_R210","doi-asserted-by":"crossref","unstructured":"Ishii M, Ueno T, Ikeda H, et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation.\u20082002;105 :3004\u2013 3010","DOI":"10.1161\/01.CIR.0000019733.56553.D8"},{"key":"2021120819410821900_R211","doi-asserted-by":"crossref","unstructured":"Checchia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics.\u20081997;100 :695\u2013 699","DOI":"10.1542\/peds.100.4.695"},{"key":"2021120819410821900_R212","doi-asserted-by":"crossref","unstructured":"Takahashi M, Mason W, Lewis AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation.\u20081987;75 :387\u2013 394","DOI":"10.1161\/01.CIR.75.2.387"},{"key":"2021120819410821900_R213","unstructured":"Fujiwara T, Fujiwara H, Hamashima Y. Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res.\u20081987;250 :519\u2013 520"},{"key":"2021120819410821900_R214","doi-asserted-by":"crossref","unstructured":"Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol.\u20081985;56 :846\u2013 851","DOI":"10.1016\/0002-9149(85)90767-2"},{"key":"2021120819410821900_R215","unstructured":"Kamiya T, Suzuki A, Ono Y, et al. Angiographic follow-up study of coronary artery lesion in the cases with a history of Kawasaki disease-with a focus on the follow-up more than ten years after the onset of the disease. In: Kato H, ed. Kawasaki Disease. Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 22\u201325, 1995. New York, NY: Elsevier Science; 1995:569\u2013573"},{"key":"2021120819410821900_R216","doi-asserted-by":"crossref","unstructured":"Fujiwara T, Fujiwara H, Hamashima Y. Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardiol.\u20081987;59 :808\u2013 811","DOI":"10.1016\/0002-9149(87)91096-4"},{"key":"2021120819410821900_R217","doi-asserted-by":"crossref","unstructured":"Nakano H, Saito A, Ueda K, Nojima K. Clinical characteristics of myocardial infarction following Kawasaki disease: report of 11 cases. J Pediatr.\u20081986;108 :198\u2013 203","DOI":"10.1016\/S0022-3476(86)80982-9"},{"key":"2021120819410821900_R218","doi-asserted-by":"crossref","unstructured":"Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr.\u20081987;111 :705\u2013 710","DOI":"10.1016\/S0022-3476(87)80246-9"},{"key":"2021120819410821900_R219","doi-asserted-by":"crossref","unstructured":"Matsui S, Matsumori A, Matoba Y, Uchida A, Sasayama S. Treatment of virus-induced myocardial injury with a novel immunomodulating agent, vesnarinone. Suppression of natural killer cell activity and tumor necrosis factor-alpha production. J Clin Invest.\u20081994;94 :1212\u2013 1217","DOI":"10.1172\/JCI117438"},{"key":"2021120819410821900_R220","doi-asserted-by":"crossref","unstructured":"Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics.\u20082001;107 :1095\u2013 1099","DOI":"10.1542\/peds.107.5.1095"},{"key":"2021120819410821900_R221","doi-asserted-by":"crossref","unstructured":"Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol.\u20081996;28 :253\u2013 257","DOI":"10.1016\/0735-1097(96)00099-X"},{"key":"2021120819410821900_R222","doi-asserted-by":"crossref","unstructured":"Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet.\u20081992;340 :1127\u2013 1129","DOI":"10.1016\/0140-6736(92)93152-D"},{"key":"2021120819410821900_R223","doi-asserted-by":"crossref","unstructured":"Tanaka N, Naoe S, Masuda H, Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn.\u20081986;36 :1513\u2013 1527","DOI":"10.1111\/j.1440-1827.1986.tb02823.x"},{"key":"2021120819410821900_R224","doi-asserted-by":"crossref","unstructured":"Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study? J Pediatr.\u20081982;100 :225\u2013 231","DOI":"10.1016\/S0022-3476(82)80639-2"},{"key":"2021120819410821900_R225","doi-asserted-by":"crossref","unstructured":"Tsuda E, Kamiya T, Kimura K, Ono Y, Echigo S. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol.\u20082002;23 :9\u2013 14","DOI":"10.1007\/s00246-001-0004-4"},{"key":"2021120819410821900_R226","doi-asserted-by":"crossref","unstructured":"Iemura M, Ishii M, Sugimura T, Akagi T, Kato H. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart.\u20082000;83 :307\u2013 311","DOI":"10.1136\/heart.83.3.307"},{"key":"2021120819410821900_R227","doi-asserted-by":"crossref","unstructured":"Fulton DR, Meissner C, Peterson MB. Effects of current therapy of Kawasaki disease on eicosanoid metabolism. Am J Cardiol.\u20081988;61 :1323\u2013 1327","DOI":"10.1016\/0002-9149(88)91177-0"},{"key":"2021120819410821900_R228","doi-asserted-by":"crossref","unstructured":"Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol.\u20082004;43 :120\u2013 124","DOI":"10.1016\/j.jacc.2003.08.030"},{"key":"2021120819410821900_R229","doi-asserted-by":"crossref","unstructured":"Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki Disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis. Circulation.\u20081988;78 :345\u2013 350","DOI":"10.1161\/01.CIR.78.2.345"},{"key":"2021120819410821900_R230","doi-asserted-by":"crossref","unstructured":"Yamakawa R, Ishii M, Sugimura T, et al. Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol.\u20081998;31 :1074\u2013 1080","DOI":"10.1016\/S0735-1097(98)00033-3"},{"key":"2021120819410821900_R231","doi-asserted-by":"crossref","unstructured":"Albisetti M, Chan AK, McCrindle BW, et al. Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease. Blood Coagul Fibrinolysis.\u20082003;14 :181\u2013 186","DOI":"10.1097\/00001721-200302000-00010"},{"key":"2021120819410821900_R232","doi-asserted-by":"crossref","unstructured":"Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J.\u20082003;22 :34\u2013 39","DOI":"10.1097\/00006454-200301000-00011"},{"key":"2021120819410821900_R233","doi-asserted-by":"crossref","unstructured":"Furuyama H, Odagawa Y, Katoh C, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr.\u20082003;142 :149\u2013 154","DOI":"10.1067\/mpd.2003.46"},{"key":"2021120819410821900_R234","doi-asserted-by":"crossref","unstructured":"Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr.\u20082001;138 :400\u2013 405","DOI":"10.1067\/mpd.2001.111430"},{"key":"2021120819410821900_R235","doi-asserted-by":"crossref","unstructured":"Furuyama H, Odagawa Y, Katoh C, et al. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation.\u20082002;105 :2878\u2013 2884","DOI":"10.1161\/01.CIR.0000018652.59840.57"},{"key":"2021120819410821900_R236","doi-asserted-by":"crossref","unstructured":"Suzuki A, Yamagishi M, Kimura K, et al. Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound. J Am Coll Cardiol.\u20081996;27 :291\u2013 296","DOI":"10.1016\/0735-1097(95)00447-5"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/6\/1708\/1022223\/zpe01204001708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/6\/1708\/1022223\/zpe01204001708.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T17:00:41Z","timestamp":1682874041000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/114\/6\/1708\/67885\/Diagnosis-Treatment-and-Long-Term-Management-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":236,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,12,1]]},"published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2182","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}